Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline plus concurrent chemoradiation and adjuvant temozolomide in newly diagnosed glioblastoma
ChiCTR2300072914Phase 2Recruiting
- Sponsor
- Tangdu Hospital
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of sertraline in glioblastoma (GBM) (2 arms), sponsored by Tangdu Hospital. Primary endpoint: Progression-Free Survival. Started Jul 2023; status: recruiting.
02
Drugs
sertraline
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on ChiCTR2300072914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072914.